The protein-profile report adds a measurement layer to earlier Semax gene-expression work. It should not be interpreted as a uniform change throughout the brain. Primary report
What was measured
The rat ischemia-reperfusion experiment assessed selected proteins at 24 hours. The abstract reports increased active CREB in subcortical structures, lower MMP-9 and c-Fos in adjacent cortex, and reduced active JNK in both sampled regions. A regulatory network was also constructed. Primary report
Our appraisal: do not drop the location or the protein state
An activated form of a protein is not necessarily the same measurement as total protein abundance. A summary that removes “active” can change the biological claim. Likewise, a regional observation does not establish the same response in every brain region.
The network provides an organized representation of relationships, but a diagram does not independently prove every causal arrow. The underlying experiments supporting each connection should be identified, particularly when some links come from prior knowledge rather than direct manipulation in the present study.
Protein data can complement RNA measurements without making them interchangeable. Different stages of regulation, sampling times, and tissue composition can produce differences between transcript and protein findings.
Full appraisal should inspect antibody validation, signal normalization, blinded quantification, biological replicates, and the selection of proteins for testing. Neither a favorable title nor a mechanistic pattern substitutes for direct assessment of clinically meaningful function.
Frequently asked questions
Were all findings from one undifferentiated brain sample?
No. The report distinguishes sampled regions.
Is active JNK identical to total JNK abundance?
No. Activation state is a distinct measurement.
Were proteins and RNA treated as interchangeable here?
They should not be; they represent different regulatory levels.
Does a constructed network prove every causal connection?
No. Each connection needs its own evidentiary basis.
Was this a human recovery trial?
No. It was an animal molecular study.
Why inspect antibody validation?
Measurement specificity affects confidence in the protein result.
What remains for release?
Complete experimental, figure, network, and publication-history review.